These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1668655)

  • 1. Diabetes is associated with a high incidence of endothelial-binding antibodies which do not correlate with retinopathy, von Willebrand factor, angiotensin-converting enzyme or C-reactive protein.
    Petty RG; Pottinger BE; Greenwood RM; Pearson JD; Mahler RF
    Diabetes Res; 1991 Jul; 17(3):115-23. PubMed ID: 1668655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
    Fioretto P; Stehouwer CD; Mauer M; Chiesura-Corona M; Brocco E; Carraro A; Bortoloso E; van Hinsbergh VW; Crepaldi G; Nosadini R
    Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
    J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.
    Blann AD; Illingworth K; Jayson MI
    J Rheumatol; 1993 Aug; 20(8):1325-30. PubMed ID: 8230013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor in diabetic retinopathy.
    Abayomi EA; Miller E; Paton RC
    Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
    Kario K; Matsuo T; Kobayashi H; Kanai N; Hoshide S; Mitsuhashi T; Ikeda U; Nishiuma S; Matsuo M; Shimada K
    J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular wall von Willebrand factor in human diabetic retinopathy.
    Boeri D; Cagliero E; Podestá F; Lorenzi M
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):600-7. PubMed ID: 8113010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium dysfunction markers in patients with diabetic retinopathy.
    Siemianowicz K; Francuz T; Gminski J; Telega A; Syzdól M
    Int J Mol Med; 2005 Mar; 15(3):459-62. PubMed ID: 15702238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
    Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
    Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.
    Spijkerman AM; Gall MA; Tarnow L; Twisk JW; Lauritzen E; Lund-Andersen H; Emeis J; Parving HH; Stehouwer CD
    Diabet Med; 2007 Sep; 24(9):969-76. PubMed ID: 17593241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
    Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
    Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin on von Willebrand factor release in normal and diabetic subjects: in vivo and in vitro studies.
    Kessler L; Azimzadeh A; Wiesel ML; Coumaros G; Chakfé N; Soyer C; Koehl C; Cazenave JP; Wolf P; Pinget M
    Horm Metab Res; 2001 Nov; 33(11):674-80. PubMed ID: 11733871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury.
    Matucci-Cerinic M; Jaffa A; Kahaleh B
    J Lab Clin Med; 1992 Sep; 120(3):428-33. PubMed ID: 1325530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor, diabetes mellitus and retinopathy.
    Paton RC; Passa P; Canivet J
    Horm Metab Res Suppl; 1981; 11():55-8. PubMed ID: 6797913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.